Åsa Petersén

6.3k total citations
104 papers, 4.8k citations indexed

About

Åsa Petersén is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Åsa Petersén has authored 104 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Cellular and Molecular Neuroscience, 50 papers in Molecular Biology and 33 papers in Neurology. Recurrent topics in Åsa Petersén's work include Genetic Neurodegenerative Diseases (70 papers), Mitochondrial Function and Pathology (31 papers) and Neurological disorders and treatments (23 papers). Åsa Petersén is often cited by papers focused on Genetic Neurodegenerative Diseases (70 papers), Mitochondrial Function and Pathology (31 papers) and Neurological disorders and treatments (23 papers). Åsa Petersén collaborates with scholars based in Sweden, Germany and Australia. Åsa Petersén's co-authors include Patrik Brundin, Maria Björkqvist, Sanaz Gabery, Lil Träskman‐Bendz, Rana Soylu-Kucharz, Oskar Hansson, Lena Brundin, Roger F. Castilho, Joana Gil‐Mohapel and Deniz Kirik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Brain.

In The Last Decade

Åsa Petersén

103 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Åsa Petersén Sweden 37 2.8k 2.5k 1.3k 695 558 104 4.8k
Birgit Liss Germany 39 3.2k 1.1× 2.8k 1.1× 1.7k 1.3× 925 1.3× 1.0k 1.8× 73 6.2k
Thomas M. Engber United States 34 3.8k 1.3× 1.9k 0.8× 2.2k 1.6× 273 0.4× 670 1.2× 61 5.3k
Stephan Züchner United States 46 2.4k 0.9× 3.2k 1.3× 1.1k 0.9× 541 0.8× 384 0.7× 177 6.6k
Hitoo Nishino Japan 38 1.9k 0.7× 1.2k 0.5× 542 0.4× 538 0.8× 821 1.5× 149 4.1k
Kouichi Nakamura Japan 33 2.5k 0.9× 1.3k 0.5× 1.0k 0.8× 317 0.5× 1.2k 2.2× 120 4.5k
Monique Touret France 24 1.5k 0.5× 632 0.3× 347 0.3× 486 0.7× 882 1.6× 48 2.9k
Oliver M. Schlüter United States 36 3.6k 1.3× 2.5k 1.0× 1.2k 0.9× 926 1.3× 1.2k 2.2× 73 5.7k
Imke Puls Germany 22 1.3k 0.5× 1.4k 0.6× 1.3k 1.0× 307 0.4× 445 0.8× 40 3.8k
Fumino Fujiyama Japan 35 3.4k 1.2× 1.4k 0.6× 825 0.6× 545 0.8× 1.7k 3.0× 79 4.8k
Sabina Berretta United States 37 2.2k 0.8× 1.3k 0.5× 252 0.2× 304 0.4× 982 1.8× 74 4.1k

Countries citing papers authored by Åsa Petersén

Since Specialization
Citations

This map shows the geographic impact of Åsa Petersén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åsa Petersén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åsa Petersén more than expected).

Fields of papers citing papers by Åsa Petersén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Åsa Petersén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åsa Petersén. The network helps show where Åsa Petersén may publish in the future.

Co-authorship network of co-authors of Åsa Petersén

This figure shows the co-authorship network connecting the top 25 collaborators of Åsa Petersén. A scholar is included among the top collaborators of Åsa Petersén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Åsa Petersén. Åsa Petersén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gabery, Sanaz, et al.. (2023). Effects of mutant huntingtin in oxytocin neurons on non‐motor features of Huntington's disease. Neuropathology and Applied Neurobiology. 49(2). e12891–e12891. 2 indexed citations
2.
Lundh, Sofia, et al.. (2022). Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models. Frontiers in Neuroscience. 16. 1027269–1027269. 2 indexed citations
3.
Gabery, Sanaz, Rebekah M. Ahmed, Jashelle Caga, et al.. (2021). Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis. Neuropathology and Applied Neurobiology. 47(7). 979–989. 38 indexed citations
4.
Dupuis, Luc, Åsa Petersén, & Patrick Weydt. (2018). Thermoregulation in amyotrophic lateral sclerosis. Handbook of clinical neurology. 157. 749–760. 6 indexed citations
5.
Pircs, Karolina, Rebecca Petri, Sofia Madsen, et al.. (2018). Huntingtin Aggregation Impairs Autophagy, Leading to Argonaute-2 Accumulation and Global MicroRNA Dysregulation. Cell Reports. 24(6). 1397–1406. 67 indexed citations
6.
Gorges, Martin, Pauline Vercruysse, Hans‐Peter Müller, et al.. (2017). Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 88(12). 1033–1041. 117 indexed citations
7.
Soylu-Kucharz, Rana, Barbara Baldo, & Åsa Petersén. (2016). Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington’s disease. Scientific Reports. 6(1). 28322–28322. 18 indexed citations
8.
Kirik, Deniz, et al.. (2016). Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands. Neurobiology of Disease. 97(Pt B). 179–188. 38 indexed citations
9.
Baldo, Barbara, Rachel Y. Cheong, & Åsa Petersén. (2014). Effects of Deletion of Mutant Huntingtin in Steroidogenic Factor 1 Neurons on the Psychiatric and Metabolic Phenotype in the BACHD Mouse Model of Huntington Disease. PLoS ONE. 9(10). e107691–e107691. 16 indexed citations
10.
Hyrskyluoto, Alise, Sofia Lundh, Hoi Tang, et al.. (2014). Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtin-induced cell degeneration: involvement of the proteasome and ER stress-activated kinase IRE1 . Human Molecular Genetics. 23(22). 5928–5939. 76 indexed citations
11.
Wörtwein, Gitta, et al.. (2011). Increased numbers of orexin/hypocretin neurons in a genetic rat depression model. Neuropeptides. 45(6). 401–406. 57 indexed citations
12.
Gabery, Sanaz, Karen E. Murphy, Clement T. Loy, et al.. (2010). Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses. Acta Neuropathologica. 120(6). 777–788. 91 indexed citations
13.
Soylu-Kucharz, Rana, et al.. (2010). Hypothalamic and Neuroendocrine Changes in Huntingtons Disease. Current Drug Targets. 11(10). 1237–1249. 33 indexed citations
14.
Schultz, Kirk R., Karin Nilsson, Suzanne Granhøj Lindquist, et al.. (2009). Transthyretin as a potential CSF biomarker for Alzheimer’s disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors. European Journal of Neurology. 17(3). 456–460. 22 indexed citations
15.
Petersén, Åsa, et al.. (2008). Nortriptyline mediates behavioral effects without affecting hippocampal cytogenesis in a genetic rat depression model. Neuroscience Letters. 451(2). 148–151. 21 indexed citations
16.
Brundin, Lena, Maria Björkqvist, Lil Träskman‐Bendz, & Åsa Petersén. (2008). Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt. Journal of Affective Disorders. 113(1-2). 179–182. 58 indexed citations
17.
Brundin, Lena, Maria Björkqvist, Åsa Petersén, & Lil Träskman‐Bendz. (2007). Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. European Neuropsychopharmacology. 17(9). 573–579. 173 indexed citations
18.
Karlsson, Jenny, Åsa Petersén, Gunilla Gidö, Tadeusz Wieloch, & Patrik Brundin. (2005). Combining Neuroprotective Treatment of Embryonic Nigral Donor Tissue with Mild Hypothermia of the Graft Recipient. Cell Transplantation. 14(5). 301–309. 16 indexed citations
19.
Petersén, Åsa & Patrik Brundin. (2002). Huntington's disease: The mystery unfolds?. International review of neurobiology. 53. 315–339. 10 indexed citations
20.
Petersén, Åsa, Mia Emgård, & Patrik Brundin. (1999). Impact of a preceding striatal excitotoxic lesion and treatment with ciliary neurotrophic factor on striatal graft survival. Brain Research Bulletin. 50(4). 275–281. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Birgit Liss Breakdown of academic impact, for papers by Thomas M. Engber Breakdown of academic impact, for papers by Stephan Züchner Breakdown of academic impact, for papers by Hitoo Nishino Breakdown of academic impact, for papers by Kouichi Nakamura Breakdown of academic impact, for papers by Monique Touret Breakdown of academic impact, for papers by Oliver M. Schlüter Breakdown of academic impact, for papers by Imke Puls Breakdown of academic impact, for papers by Fumino Fujiyama Breakdown of academic impact, for papers by Sabina Berretta
Rankless by CCL
2026